Genome editing in stem cells for genetic neurodisorders
Prog Mol Biol Transl Sci. 2021;182:403-438. doi: 10.1016/bs.pmbts.2020.12.006. Epub 2021 Jan 30.ABSTRACTThe recent advent of genome editing techniques and their rapid improvement paved the way in establishing innovative human neurological disease models and in developing new therapeutic opportunities. Human pluripotent (both induced or naive) stem cells and neural stem cells represent versatile tools to be applied to multiple research needs and, together with genomic snip and fix tools, have recently made possible the creation of unique platforms to directly investigate several human neural affections. In this chapter, we will discuss genome engineering tools, and their recent improvements, applied to the stem cell field, focusing on how these two technologies may be pivotal instruments to deeply unravel molecular mechanisms underlying development and function, as well as disorders, of the human brain. We will review how these frontier technologies may be exploited to investigate or treat severe neurodevelopmental disorders, such as microcephaly, autism spectrum disorder, schizophrenia, as well as neurodegenerative conditions, including Parkinson's disease, Huntington's disease, Alzheimer's disease, and spinal muscular atrophy.PMID:34175049 | DOI:10.1016/bs.pmbts.2020.12.006
Source: Mol Biol Cell - Category: Molecular Biology Authors: Claudia Dell' Amico Alice Tata Enrica Pellegrino Marco Onorati Luciano Conti Source Type: research
More News: Alzheimer's | Autism | Brain | Genetics | Huntington's Disease | Molecular Biology | Neurology | Parkinson's Disease | Schizophrenia | Spinal Muscular Atrophy | Stem Cell Therapy | Stem Cells